title: Opioid substitution and HIV/AIDS treatment and prevention.
authors.affiliation: British Columbia Centre for Excellence in HIV/AIDS, St Paul's Hospital, Vancouver, British Columbia, Canada V6Z 1Y6. tkerr@cfenet.ubc.ca
authors.forename: Thomas
authors.initials: T
authors.lastname: Kerr
authors.forename: Alex
authors.initials: A
authors.lastname: Wodak
authors.forename: Richard
authors.initials: R
authors.lastname: Elliott
authors.forename: Julio S
authors.initials: JS
authors.lastname: Montaner
authors.forename: Evan
authors.initials: E
authors.lastname: Wood
mesh_terms: D017954:Africa South of the Sahara / Q000453:epidemiology; D002047:Buprenorphine / Q000627:therapeutic use*; D015658:HIV Infections / Q000150:complications / Q000188:drug therapy* / Q000453:epidemiology / Q000517:prevention & control; D006297:Health Services Accessibility; D006801:Humans; D008691:Methadone / Q000627:therapeutic use*; D009293:Opioid-Related Disorders / Q000150:complications / Q000453:epidemiology / Q000534:rehabilitation*; D015995:Prevalence; D014944:World Health Organization
chemical_list: D002047:Buprenorphine; D008691:Methadone